rdf:type |
|
lifeskim:mentions |
umls-concept:C0005477,
umls-concept:C0013080,
umls-concept:C0017480,
umls-concept:C0017504,
umls-concept:C0024915,
umls-concept:C0205147,
umls-concept:C0220908,
umls-concept:C0229671,
umls-concept:C0439230,
umls-concept:C0596545,
umls-concept:C1449855,
umls-concept:C1858460
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-4-7
|
pubmed:abstractText |
To examine the efficacy of first trimester screening for trisomy 21 using a combination of maternal age, fetal nuchal translucency (NT), maternal serum free beta-human chorionic gonadotropin (free beta-hCG) and pregnancy-associated plasma protein A (PAPP-A) in a regional setting [maternity unit of the Women's University Hospital, Hannover Medical School (study center); two regional private centers for prenatal diagnosis and human genetics; laboratory for prenatal diagnosis and human genetics].
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1015-3837
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2006 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
264-8
|
pubmed:meshHeading |
pubmed-meshheading:16601335-Adult,
pubmed-meshheading:16601335-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:16601335-Crown-Rump Length,
pubmed-meshheading:16601335-Down Syndrome,
pubmed-meshheading:16601335-False Positive Reactions,
pubmed-meshheading:16601335-Female,
pubmed-meshheading:16601335-Germany,
pubmed-meshheading:16601335-Gestational Age,
pubmed-meshheading:16601335-Humans,
pubmed-meshheading:16601335-Maternal Age,
pubmed-meshheading:16601335-Nuchal Translucency Measurement,
pubmed-meshheading:16601335-Pregnancy,
pubmed-meshheading:16601335-Pregnancy Outcome,
pubmed-meshheading:16601335-Pregnancy-Associated Plasma Protein-A,
pubmed-meshheading:16601335-Prenatal Diagnosis,
pubmed-meshheading:16601335-Sensitivity and Specificity
|
pubmed:year |
2006
|
pubmed:articleTitle |
Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Division of Prenatal Medicine, Hannover Medical School, Germany.
|
pubmed:publicationType |
Journal Article
|